Jim Simons acquired 18k Palvella Therapeutics shares worth $2.06M. That's 0.00% of their equity portfolio (1856th largest holding). The first Palvella Therapeutics trade was made in Q4 2024. Since then Jim Simons bought shares two more times and sold shares on three occasions. The stake costed the investor $536k, netting the investor a gain of 285% so far.